I hope this finds everyone well. This week we have received good news from two different clinical trials with interferon-free therapies. AbbVie and Gilead are reporting cure rates in the 90 percentile! To read about these therapies and other news check out our blog. In addition, we have updated many fact sheets and guides to include information about the recently FDA-approved Sovaldi (sofosbuvir) combination therapy as well as information about Olysio (simeprevir) that was approved a couple of weeks ago.